Caas Capital Management LP Novavax Inc Transaction History

Caas Capital Management LP

  • $1.31 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$8.86 - $25.04 $8.86 Million - $25 Million
1,000,000 New
1,000,000 $10.3 Million
Q1 2022

May 13, 2022
SELL
$69.73 - $142.9 $68,265 - $139,899
-979 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$134.56 - $217.97 $131,734 - $213,392
979 New
979 $140,000

Others Institutions Holding NVAX

# of Institutions
242
Shares Held
76.1M
Call Options Held
5.06M
Put Options Held
7.19M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $1.01B
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email